COSTANTE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 2.876
AS - Asia 1.745
EU - Europa 567
SA - Sud America 348
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 5.581
Nazione #
US - Stati Uniti d'America 2.784
SG - Singapore 795
CN - Cina 487
BR - Brasile 272
IT - Italia 196
IN - India 170
VN - Vietnam 169
SE - Svezia 133
GB - Regno Unito 83
CA - Canada 64
DE - Germania 64
AR - Argentina 35
HK - Hong Kong 25
MX - Messico 20
EC - Ecuador 14
BD - Bangladesh 13
ID - Indonesia 13
IR - Iran 13
UA - Ucraina 13
BE - Belgio 11
FI - Finlandia 11
JP - Giappone 10
RU - Federazione Russa 10
ZA - Sudafrica 10
IQ - Iraq 7
PL - Polonia 7
RO - Romania 7
UZ - Uzbekistan 7
ES - Italia 6
EU - Europa 6
PY - Paraguay 6
SA - Arabia Saudita 6
TR - Turchia 6
CO - Colombia 5
MA - Marocco 5
NL - Olanda 5
CL - Cile 4
PE - Perù 4
TN - Tunisia 4
AU - Australia 3
EG - Egitto 3
FR - Francia 3
KE - Kenya 3
PK - Pakistan 3
PT - Portogallo 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
IL - Israele 2
JO - Giordania 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 5.581
Città #
San Jose 460
Chandler 444
Dallas 220
Ashburn 205
Singapore 189
Santa Clara 152
Bengaluru 142
Hefei 141
Princeton 137
Lawrence 135
Milan 132
Wilmington 92
Ho Chi Minh City 68
London 66
Chicago 65
Ottawa 48
Beijing 44
Des Moines 43
Munich 42
Hanoi 41
Shanghai 28
São Paulo 26
Hong Kong 25
Los Angeles 21
Guangzhou 19
Boardman 14
Norwalk 14
Shenzhen 14
Brooklyn 13
Catania 13
San Francisco 11
New York 10
Pune 10
Turku 10
Guayaquil 9
The Dalles 9
Da Nang 8
Redmond 8
Tokyo 8
Chennai 7
Council Bluffs 7
Haiphong 7
Horia 7
Jiaxing 7
Monterrey 7
Xi'an 7
Columbus 6
Curitiba 6
Hanover 6
Johannesburg 6
Manaus 6
Merksem 6
Tashkent 6
Warsaw 6
Wuhan 6
Atlanta 5
Brasília 5
Brussels 5
Quito 5
Rio de Janeiro 5
Thái Bình 5
Wuxi 5
Belo Horizonte 4
Catanzaro 4
Guadalupe 4
Houston 4
Manchester 4
Phoenix 4
Redwood City 4
Rui'an 4
Seattle 4
Sumaré 4
Toronto 4
Viamão 4
Ann Arbor 3
Baghdad 3
Belém 3
Bismarck 3
Boston 3
Bắc Ninh 3
Casablanca 3
Charlotte 3
Dongyang 3
Falls Church 3
Franca 3
Goiânia 3
Hangzhou 3
Lima 3
Marília 3
Milwaukee 3
Nairobi 3
Naples 3
Ninh Bình 3
Nova Iguaçu 3
Orem 3
Poplar 3
Porto Alegre 3
San Diego 3
São José dos Campos 3
Tehran 3
Totale 3.400
Nome #
Hashimoto's thyroiditis and vestibular dysfunction 77
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation 77
A novel double mutation val648ile and val804leu of ret proto-oncogene in multiple endocrine neoplasia type 2 76
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 73
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 73
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 73
Calcitonin as a biomarker of C cell disease: recent achievements and current challenges 68
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization 68
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 67
Characterization of visual field alterations in patients with thyroid associated ophthalmopathy 62
Identification and optimal postsurgical follow-up of patients with very-low-risk papillary thyroid microcarcinoma 61
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study 59
Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fcε receptor by a recombinant human autoantibody Fab converted to IgE 59
Absence of circulating desialylated thyroxine-binding globulin in patients wiht hepatobiliary disease 59
Amiodarone 59
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 57
Alcune prospettive per la medicina clinica. La biologia molecolare 57
Multikinase inhibitors for the treatment of radioiodine refractory thyroid cancer: what have we learned from the 'real-world' experience? 57
Vestibular disorders in euthyroid patients with Hashimoto’s thyroiditis: role of thyroid autoimmunity. 56
Calcitonin screening in patients scheduled for thyroidectomy for nodular disorders. (e-letter) 55
Absence of circulating desialylated thyroxine-binding globulin in patients with hepatobiliary disease 55
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 55
Amiodarone (letter) 54
Correlation between saccadic parameter variations and clinical evidences in thyroid autoimmune ophthalmopathy (TAO) affected patients 54
Differentiated thyroid carcinoma: Defining new paradigms for postoperative management 54
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 53
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma 53
Thyroid peroxidase autoantibody fingerprints: I. A cross sectional study in elderly women. J. Clin. Endocrinol. Metab 52
Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by an autoantibody Fab converted to IgE 51
Recombinant thyroid peroxidase autoantibodies can be used for epitopic “fingerprinting” of thyroid peroxidase autoantibodies in the sera of individual patients 49
Different molecular mechanisms are involved in the multihormonal control of glucose transport in FRTL-5 rat thyroid cells 49
Recombinant human thyrotropin receptor in a radioreceptor assay for the measurement of TSH receptor autoantibodies 48
Papillary thyroid cancer. Time course of recurrences during post-surgery surveillance. 47
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivate 46
Early diagnosis of compressive optic neuropathy (NOC) in patients with Thyroid Autoimmune Ophthalmopathy (TAO). 46
Iodine deficiency in Calabria: characterization of endemic goiter and analysis of different indicators of iodine status regionwide 46
Compressive optic neuropathy in patients with Thyroid Associated Ophthalmopathy 46
The Natural History of Benign Thyroid Nodules 45
L-Tiroxina suppressive treatment has no beneficial effect on thyroid nodules after menopause 45
Algoritmo diagnostico delle malattie tiroidee 45
Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy 44
hNIS protein in thyroid: the iodine supply influences its expression and localization 44
Temporal changes in thyroid nodule volume: lack of effect on paranodular thyroid tissue volume 44
Slow growth of benign thyroid nodules after menopause: no need for long term thyroxine suppressive therapy in post-menopausal women 43
Early diagnosis of medullary thyroid carcinoma: Is systematic calcitonin screening appropriate in patients with thyroid nodular disease? 43
Calctonin and Carcinoembryonic antigen for the diagnosis and management of Medullary Thyroid Carcinoma. 43
Follow-up of low-risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases 43
Multiple Endocrine Neoplasia 2 43
Recombinant thyroid specific autoantibodies: II. Role of individual heavy and light chains in determining epitope recognition 42
Effectiveness of L-Thyroxine treatment for the prevention of nodular goiter recurrence in an endemic goiter area 42
Low serum thyrotropin concentrations as a risk factor for Atrial Fibrillation in elderly patients 42
Tecnologia del DNA ricombinante nello studio delle malattie tiroidee autoimmuni. Identificazione della tireoperossidasi (TPO) 42
Predictive value of serum Calcitonin levels for preoperative diagnosis of Medullary Thyroid Carcinoma in a cohort of 5817 consecutive patients with thyroid nodules 42
hNIS protein in thyroid: the iodine supply influences its expression and localization. Thyroid 42
Subclinical optic nerve involvement in patients with thyroid-associated ophthalmopathy 42
Early identification of a ret proto-oncogene somatic mutation in fine needle aspiration biopsy (FNAB) of a medullary thyroid carcinoma 42
Reproductive life and differentiated thyroid carcinoma in women: reciprocal influences on their respective outcome 41
The immunodominant region on human thyroid peroxidase recognized by autoantibodies does not contain the monoclonal antibody 47/c21 linear epitope 41
Severe Graves' Orbitopathy occurring in a patient with thyroid hemiagenesis. 41
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas 41
Effects of active immunization against l-triiodothyronine on serum thyrotropin and liver alpha-glycerophospate dehydrogenase activity in rats: evidence for reduced hormone disposal to cells 40
Ruolo aritmogeno dell’ipertiroidismo subclinico: bassi livelli di TSH come fattore di rischio per la comparsa della fibrillazione atriale nei soggetti anziani 40
Neck ultrasonography in the follow-up of low risk patients with papillary thyroid cancer (PTC) 40
Thyroid carcinoma and thyrotoxicosis 40
Failure to find evidence of immunoglobulin inhibitor(s) of thyroid hormone binding protein in non-thyroid illnesses 39
T4 antibodies and thyroxine-binding globulin (TBG) immunoradiometric assay 39
Screening Leading to Diagnosis of C-Cell Hyperplasia 39
Ruolo dell’ecografia del collo nel follow-up a 5 anni dei pazienti affetti da carcinoma papillifero della tiroide a basso rischio 39
Metformin therapy decreases serum TSH levels in patients submitted to L-thyroxine treatment 39
Low serum Thyrotropin concentrations as a risk factor for atrial fibrillation in elderly subjects 39
Circulating immunoglobulin E (IgE) antibodies to l-thyroxine in a euthyroid patient with multinodular goiter and allergic rhinitis 38
Papillary thyroid carcinoma in struma ovarii 38
Thyroid diseases in the fetus 38
Un raro caso di morbo di Basedow monolaterale intollerante al trattamento con tionamidi 38
Thyroid hormones regulate red blood cell Ca2+-dependent ATPase activity through a "non hormonal" mechanism 38
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates 38
Lack of relationship between cAMP desensitization and TSH receptor down-regulation in the rat thyroid cell line FRTL5 38
Specific autoantibody binding to thyroid peroxidase: dominant role of the light chain in determining epitope recognition 37
Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. 37
Correlazione tra le modifiche dei parametri saccadici e le manifestazioni cliniche nei pazienti con oftalmopatia tiroidea autoimmune 37
In vitro effects of thyroid hormones on red blood cell Ca2+-dependent ATPase activity 37
Recurrence of nodular goiter: evidence for a prophylatic role of postoperative L- Tiroxine treatment in a moderate iodine deficiency area 37
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: Is there a role for serum thyroglobulin measurement? 36
IODINE STATUS IN INDIVIDUALS: AN ITALIAN PERSPECTIVE 36
Multifocality in Sporadic Medullary Thyroid Carcinoma: An International Multicenter Study 36
Screening leading to C cell hyperplasia 36
CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas 35
Long lasting prophylaxis of iodine deficiency after a successful information campaign for iodized salt consumption 35
Identification and characterization of circulating thyroid.hormone binding auto-antibodies in thyroid disease, in autoimmune non thyroid illnesses and lymphoreticular system disorders 35
SUBCLINICAL VISUAL FIELD ALTERATIONS IN THYROID ASSOCIATED OPHTHALMOPATHY PATIENTS 35
Novel therapeutic options for radioiodine-refractory thyroid cancer: Redifferentiation and beyond 35
Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies. 34
Stimulation of liver mitochondrial alpha-glycerophosphate dehydrogenase activity by l-thyroxine in thyroidectomized rats: comparison with the suppression of pituitary TSH secretion 34
Fibrillazione atriale nei soggetti anziani: ruolo aritmogeno dell’ipertiroidismo subclinico 34
Thyroglobulin in fine needle aspirate—a clue to metastasis? 34
Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomas 34
HbA1c levels in patients with gestational diabetes mellitus: relationship with pre-pregnancy body mass index and pregnancy outcome. 33
Identification of a Neck Lump as a Lymph Node Metastasis from an Occult Contralateral Papillary Microcarcinoma of the Thyroid: Key role of Thyroglobulin Assay in the Fine needle Aspirate 33
Recombinant thyroid peroxidase autoantibodies: I. How diverse is the pool of heavy and light chains in immunoglobulin gene libraries constructed from thyroid tissue infiltrating plasma cells? 33
Pregnancy-related hormonal changes and thyroid growth: do they have an impact on the higher incidence of differentiated thyroid cancer in women? 32
Totale 4.598
Categoria #
all - tutte 58.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 1 3 0
2021/2022388 2 1 4 89 46 5 10 87 30 28 68 18
2022/20231.107 277 58 10 110 131 95 1 106 198 61 48 12
2023/2024288 78 35 29 16 15 87 10 4 0 1 4 9
2024/20251.246 190 123 91 55 52 160 9 34 166 79 73 214
2025/20262.456 88 322 301 469 285 73 356 184 296 82 0 0
Totale 5.634